111 related articles for article (PubMed ID: 37185018)
21. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
[TBL] [Abstract][Full Text] [Related]
22. Major salivary gland lesions: correlation of MR findings with flow cytometric DNA analysis and prognosis.
Takashima S; Sone S; Horii A; Okamoto S; Yoshida J
AJR Am J Roentgenol; 1996 Nov; 167(5):1297-304. PubMed ID: 8911200
[TBL] [Abstract][Full Text] [Related]
23. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging.
Zhang Z; Song C; Zhang Y; Wen B; Zhu J; Cheng J
Dentomaxillofac Radiol; 2019 Oct; 48(7):20190100. PubMed ID: 31265331
[TBL] [Abstract][Full Text] [Related]
24. Mucoepidermoid carcinoma of the parotid gland: A National Cancer Database study.
Rajasekaran K; Stubbs V; Chen J; Yalamanchi P; Cannady S; Brant J; Newman J
Am J Otolaryngol; 2018; 39(3):321-326. PubMed ID: 29559174
[TBL] [Abstract][Full Text] [Related]
25. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.
Ma G; Xu XQ; Zhu LN; Jiang JS; Su GY; Hu H; Bu SS; Wu FY
Korean J Radiol; 2021 Feb; 22(2):243-252. PubMed ID: 32932565
[TBL] [Abstract][Full Text] [Related]
26. Added value of susceptibility-weighted imaging to diffusion-weighted imaging in the characterization of parotid gland tumors.
Jiang JS; Zhu LN; Chen W; Chen L; Su GY; Xu XQ; Wu FY
Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2839-2846. PubMed ID: 32328768
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant radiotherapy in node-negative salivary malignancies of the parotid gland: A multi-institutional analysis.
Park JB; Wu HG; Kim JH; Lee JH; Ahn SH; Chung EJ; Eom KY; Jeong WJ; Kwon TK; Kim S; Wee CW
Radiother Oncol; 2023 Jun; 183():109554. PubMed ID: 36813174
[TBL] [Abstract][Full Text] [Related]
28. Pre-treatment MRI predictor of high-grade malignant parotid gland cancer.
Baba A; Kessoku H; Akutsu T; Shimura E; Matsushima S; Kurokawa R; Ota Y; Suzuki T; Kawasumi Y; Yamauchi H; Ikeda K; Ojiri H
Oral Radiol; 2021 Oct; 37(4):611-616. PubMed ID: 33389599
[TBL] [Abstract][Full Text] [Related]
29. Classification of parotid gland tumors by using multimodal MRI and deep learning.
Chang YJ; Huang TY; Liu YJ; Chung HW; Juan CJ
NMR Biomed; 2021 Jan; 34(1):e4408. PubMed ID: 32886955
[TBL] [Abstract][Full Text] [Related]
30. Volumetric Analysis of Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Predicting the Response to Chemotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.
Jiang J; Leng Y; Liu J; Yin J; Xiao Y; Gu X; Zhang L; Fu Y; Xu G; Cui L
J Comput Assist Tomogr; 2022 May-Jun 01; 46(3):406-412. PubMed ID: 35405718
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors.
Choi SY; Lee E; Kim E; Chung MK; Son YI; Baek CH; Jeong HS
BMC Cancer; 2021 Feb; 21(1):178. PubMed ID: 33602169
[TBL] [Abstract][Full Text] [Related]
32. MRI findings of epithelial-myoepithelial carcinoma of the parotid gland with radiologic-pathologic correlation.
Suto T; Kato H; Kawaguchi M; Kobayashi K; Miyazaki T; Ando T; Noda Y; Hyodo F; Matsuo M; Ishihara H; Ogawa T
Jpn J Radiol; 2022 Jun; 40(6):578-585. PubMed ID: 34982376
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of pretreatment MRI texture features in breast cancer brain metastasis treated with Gamma Knife radiosurgery.
Zheng Y; Geng D; Yu T; Xia W; She D; Liu L; Yin B
Acta Radiol; 2021 Sep; 62(9):1208-1216. PubMed ID: 32910684
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Factors of Disease Recurrence in Breast Cancer Using Quantitative and Qualitative Magnetic Resonance Imaging (MRI) Parameters.
Lee J; Kim SH; Kang BJ
Sci Rep; 2020 May; 10(1):7598. PubMed ID: 32371907
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Factors Associated With Decreased Survival in Patients With Acinic Cell Carcinoma of the Parotid Gland.
Liu Y; Su M; Yang Y; Zhao B; Qin L; Han Z
J Oral Maxillofac Surg; 2017 Feb; 75(2):416-422. PubMed ID: 27474461
[TBL] [Abstract][Full Text] [Related]
36. MRI-based texture analysis to differentiate the most common parotid tumours.
Sarioglu O; Sarioglu FC; Akdogan AI; Kucuk U; Arslan IB; Cukurova I; Pekcevik Y
Clin Radiol; 2020 Nov; 75(11):877.e15-877.e23. PubMed ID: 32703544
[TBL] [Abstract][Full Text] [Related]
37. High-Resolution MRI Microscopy Coil Assessment of Parotid Masses.
Ginat DT; Christoforidis G
Ear Nose Throat J; 2019; 98(9):562-565. PubMed ID: 30961381
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic Features and Prognostic Factors of Widely Invasive Carcinoma Ex Pleomorphic Adenoma of Parotid Gland: A Clinicopathologic Analysis of 126 Cases in a Chinese Population.
Hu Y; Xia L; Zhang C; Xia R; Tian Z; Li J
J Oral Maxillofac Surg; 2020 Dec; 78(12):2247-2257. PubMed ID: 32649893
[TBL] [Abstract][Full Text] [Related]
39. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors.
Ma G; Zhu LN; Su GY; Hu H; Qian W; Bu SS; Xu XQ; Wu FY
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2151-2157. PubMed ID: 29961924
[TBL] [Abstract][Full Text] [Related]
40. Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer.
Chen BB; Lu YS; Yu CW; Lin CH; Chen TW; Wei SY; Cheng AL; Shih TT
Eur Radiol; 2018 Nov; 28(11):4860-4870. PubMed ID: 29770848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
